Liver cancer cells are sensitive to Lanatoside C induced cell death independent of their PTEN status by Durmaz I. et al.
Phytomedicine 23 (2016) 42–51
Contents lists available at ScienceDirect
Phytomedicine
journal homepage: www.elsevier.com/locate/phymed
Liver cancer cells are sensitive to Lanatoside C induced cell death
independent of their PTEN status
Irem Durmaz a, Ebru Bilget Guven a, Tulin Ersahin b, Mehmet Ozturk c, Ihsan Calis d,
Rengul Cetin-Atalay a,b,∗
a Department of Molecular Biology and Genetics, Faculty of Science, Bilkent University, Ankara, Turkey
b Cancer Systems Biology Laboratory, Graduate School of Informatics, METU, 06800 Ankara, Turkey
c Izmir Biomedicine and Genome Center, Faculty of Medicine, Dokuz Eylul University, Izmir, Turkey
d Department of Pharmacognosy, Faculty of Pharmacy, Near East University, Lefkosa (Nicosia), N. Cyprus
a r t i c l e i n f o
Article history:
Received 13 August 2015
Revised 6 November 2015








a b s t r a c t
Background: Hepatocellular carcinoma is the second deadliest cancer with limited treatment options. Loss
of PTEN causes the P13K/Akt pathway to be hyperactive which contributes to cell survival and resistance to
therapeutics in various cancers, including the liver cancer. Hence molecules targeting this pathway present
good therapeutic strategies for liver cancer.
Hypothesis: It was previously reported that Cardiac glycosides possessed antitumor activity by inducing apop-
tosis of multiple cancer cells through oxidative stress. However, whether Cardiac glycoside Lanatoside C can
induce oxidative stress in liver cancer cells and induce cell death both in vitro and in vivo remains unknown.
Methods: Cell viability was measured by SRB assay. Cell death analysis was investigated by propidium iodide
staining with flow cytometry and PARP cleavage. DCFH-DA staining and cytometry were used for intracellular
ROS measurement. Protein levels were analyzed by western blot analysis. Antitumor activity was investigated
on mice xenografts in vivo.
Results: In this study, we found that Cardiac glycosides, particularly Lanatoside C from Digitalis ferruginea
could significantly inhibit PTEN protein adequate Huh7 and PTEN deficient Mahlavu human liver cancer cell
proliferation by the induction of apoptosis and G2/M arrest in the cells. Lanatoside C was further shown to
induce oxidative stress and alter ERK and Akt pathways. Consequently, JNK1 activation resulted in extrinsic
apoptotic pathway stimulation in both cells while JNK2 activation involved in the inhibition of cell survival
only in PTEN deficient cells. Furthermore, nude mice xenografts followed by MRI showed that Lanatoside
C caused a significant decrease in the tumor size. In this study apoptosis induction by Lanatoside C was
characterized through ROS altered ERK and Akt pathways in both PTEN adequate epithelial and deficient
mesenchymal liver cancer cells.
Conclusion: The results indicated that Lanatoside C could be contemplated in liver cancer therapeutics, partic-
ularly in PTEN deficient tumors. This is due to Lanatoside C’s stress inducing action on ERK and Akt pathways
through differential activation of JNK1 and JNK2 by GSK3β .
© 2016 Elsevier GmbH. All rights reserved.
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Hepatocellular carcinoma is the sixth most common and one of
he most fatal cancer type worldwide (Ferlay et al. 2012). Further-
ore, incidence of HCC has been recently increased among individ-
als with obesity related liver disease in developed countries. Al-
hough the etiological factors that are thought to be fundamentally
elated to HCC are well-known (such as viral infections, toxic in-
ury and recently obesity), there are still limited treatment options
Baffy et al. 2012). This is due to the fact that liver cancer cells
re extremely resistant to conventional chemotherapy and radiother-
py. With the exception of Sorafenib, which generated notably mod-
st clinical response, no well-known target-specific drug provided















































































































atisfactory clinical response to HCC in clinical assays (El-Serag et
l. 2008). The five-year survival rate of HCC is only about seven per-
ent and the recurrence rate is very high. Therefore, it is essential to
ecommend novel preventive or therapeutic approaches towards HCC
Yau et al. 2009).
Cancer cells acquire survival capacities by altering more than a
ingle protein/pathway in parallel. Hence in these cancerous cells,
here are proteins which exhibit altered functions in favor of cell sur-
ival and anti-proliferative cellular activities. Therefore, molecules
argeting these signaling pathways are good candidates for targeted
herapies (Ersahin et al. 2015). A good example to the alteration
f mechanism in cancer cells would be the hyper-activation of the
I3K/Akt signaling pathway and hyperactivity of this pathway is fre-
uently associated with numerous cancer types. PI3K/Akt pathway is
nvolved in cell survival, proliferation, growth and metabolism and
ence any changes in this pathway can alter key mechanisms re-
uired for cell survival and lead to various cancers (Ke et al. 2011).
n HCC, constitutively active PI3K/Akt signaling due to loss of tumor
uppressor protein PTEN is significantly associated with aggressive
umor behavior (Buontempo et al. 2011). Activation of PI3K/Akt/GSK-
β pathway in several cases of liver cancer was reported to induce
MT which promoted tumor invasion and metastasis (Shearn et al.
011). Ras/Raf/MEK/ERK pathway, which also controls of cell survival
echanisms in liver cancer, has cross-talks with PI3K/Akt/GSK-3β
athway. Activation of ERK protein has dual effects on cell survival
nd death. Stress induced ERK activation can also promote cell death;
herefore in some conditions where there are cross-talks between
hese pathways, Akt and ERK proteins have anti- and pro-apoptotic
ctions respectively (Cagnol and Chambard 2010).
Cardiac glycosides are steroid-like compounds and their main
ource is the Digitalis genus and many cell-signaling mechanisms
ave been described for their anticancer activities (Prassas and Dia-
andis 2008). One of the main mechanisms is based on the inhibition
f Na+/K+-ATPase by cardiac glycosides and involves Ras pathway ac-
ivation, which leads to the release of ROS, resulting in apoptosis. Bu-
alin, a member of cardiac glycoside family, was previously shown to
nduce ROS and SAPK/JNK pathway activation in human colon cancer
ells (Xie et al. 2011). Another cardiac glycoside ouabain was also de-
cribed to induce ROS in lung cancer cells, activate JNK and PI3K/Akt
ignaling in myocyte proliferation (Liu et al. 2007). Even though there
re various studies, which show the effects of these natural drugs in
arious cancer cells, their effects on HCC are still not known. In this
tudy, cytotoxicities of pure glycosides, which were originated from
. ferruginea, in liver cancer cells were investigated. The study also
nalyzed the underlying molecular cellular pathways for this activ-
ty in drug resistant PTEN deficient mesenchymal like Mahlavu liver
ancer cells and drug sensitive PTEN adequate epithelial like Huh7
ells (Buontempo et al. 2011). It was demonstrated that ROS induced
ctions of glycosides alternatively modified Akt and ERK pathways in
hese two cells with different genetic backgrounds.
This study investigates the antitumor activity of cardiac glyco-
ides, particularly Lanatoside C, in liver cancer cells both in vitro and
n vivo. For this purpose, initially the cytotoxic activities of Lanato-
ide C along with other glycosides were tested on liver cancer cells.
anatoside C was further analyzed at molecular level in order to iden-
ify the cellular pathways involved in this activity. Finally, the antitu-
or activity was exploited in nude mice xenograft models with PTEN
eficient Mahlavu cell lines.
aterials and methods
xtraction and fractionation of glycosides
Glycosides were obtained from Digitalis ferruginea (also known as
rusty foxglove”, Aladağ – Bolu, Turkey). Initial and majority of in
itro experiments were done with pure Lanatoside C (D. ferruginea)nd further in vivo and in vitro studies were performed with Lanato-
ide C from Sigma Aldrich (≥95% purity by TLC, CID 656630) for ver-
atility. Extraction and fractionation of cardioactive glycosides were
one as described in the previous study (Calis et al. 1999a, 1999b).
he air-dried and powdered aerial parts of the plant were extracted
wice with MeOH–H2O (4:1). The water-soluble part of the extract
as fractionated by VLC using LiChroprep C-18 as stationary phase
nd was eluted with increasing amount of MeOH in MeOH–H2O mix-
ures. Fractions, which were more than 95% pure, were monitored
y thin layer chromatography (TLC) and similar fractions were com-
ined to yield ten fractions (Calis et al. 1999a). Fractions, which were
ositive to Kedde reaction, yielded cardio-active glycosides Lanato-
ide A, Lanatoside C, Glucogitoroside by the help of a series of col-
mn chromatography. Fraction eluted with water in VLC was rich in
henylethanoid glycosides. It was further subjected to MPLCon re-
ersed phase material (LiChroprep C-18) and column chromatogra-
hy as described in previous study to give Lugrandoside, Ferrugino-
ides A and B (Calis et al. 1999b)
ell lines
Epithelial-like (Huh7, HepG2) and mesenchymal-like (FOCUS,
ahlavu) human liver cancer cell lines (Buontempo et al. 2011;
uzugullu et al. 2009) were grown in DMEM with 10% fetal bovine
erum, 1% non-essential amino acids and 1% penicillin/streptomycin
GIBCO, Invitrogen) at 37 °C under 5% CO2. Cell lines were authenti-
ated with short tandem repeat DNA profiling.
CI-60 Sulphorhodamine B (SRB) assay
Cells were grown in 96-well plates (1000–2000 cells/well) for
4 h. Then they were treated with various concentrations of glyco-
ides. After 72 h, cells were fixed using cold, 10% (v/v) trichloroacetic
cid (Merck). 0.4% (m/v) SRB (Sigma Aldrich) in 1% acetic acid solution
as applied to the plates for 10 min. The unbound SRB was washed
ith 1% acetic acid. SRB was then solubilized in 10 mM Tris-base so-
ution. The absorbance was read at 515 nm. The experiments were
one in triplicates and IC50 values calculated (R
2 ≥ 0.8).
eal-time cell growth surveillance by cell electronic sensing
Human cancer cells (1000–2000 cells/well) were plated onto E-
lates and the proliferation curve of the cells was obtained by real-
ime cell electronic sensing (RT-CES, ACEA). In this experiment, the
ell index (CI) values represented cell impedance. Thus, the inhibitory
ffects of the glycosides in response to DMSO controls were deter-
ined by calculating CIglycoside/CIDMSO. The experiment was done in
riplicate.
mmunofluorescence staining
Cancer cells were inoculated on coverslips in six-well plates
30,000–100,000 cells/well) and after 24 h, they were treated with
he glycosides with 2 μM or DMSO controls. Then the cells were
xed with 100% ice-cold methanol and stained with 1 μg/ml Hoechst
33258, Sigma Aldrich). Finally, the cells were observed under a fluo-
escent microscope.
estern blot
Mahlavu cells were treated with either glycosides (2 μM) or
MSO control. 20–50 ng of protein was used per well (NuPAGE)
or electrophoresis, which were then transferred to nitrocellulose
embranes and blotted with specific antibodies (Cleaved caspase-
(9746S Cell Signaling), p-Akt (Ser473) (9271 Cell Signaling),
kt (9272 Cell Signaling), p-ERK1/2(Thr202/Tyr204) (sc16982 Santa
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Fig. 1. Chemical structures of the cardiac glycosides, Lanatoside A (1), Lanatoside C (2)
















































Cruz), ERK1/2 (sc135900 Santa Cruz), SAPK/JNK (9252 Cell Sig-
naling), pSAPK/JNK (Thr183/Tyr185) (4671 Cell Signaling), p-GSK3-
α/β (Ser21/9) (9331 Cell Signaling), GSK3-α/β (sc7291 Santa Cruz),
Na+/K+-ATPase α1 subunit (3010 Cell Signaling), PARP (9532 Cell Sig-
naling) and cleaved caspase-3 (9662S Cell Signaling). Antibodies were
diluted in 1:100–500 5% BSA-TBS-T. Actin (Sigma, A5441), Calnexin
(C4731 Sigma Aldrich) antibodies used for equal loading.
Flow cytometry analysis
Liver cancer cells were treated with the glycosides (2 μM) or
DMSO control for 24 h and were then resuspended in Propidium io-
dide solution for 40 min (50 μg/ml PI (Sigma Aldrich), 0.1 mg/ml
RNaseA (Fermentas), 0.05% Tritron-X-100, 1X PBS). Samples were an-
alyzed using CellQuest software (Becton Dickinson).
Oxidative stress assay
Cells were inoculated into 100 mm culture dish (100,000–300,000
cells/dish) for 24 h. Then 2 μM Lanatoside C (L2261, Sigma Aldrich)
was applied to the cells. One group of cells did not receive the
compound but they were grown in selenium deficient serum-free
medium as positive control for oxidative stress (Irmak et al. 2003).
Third group was treated with DMSO as negative control. After 6 h and
12 h, the cells were collected and analyzed by MUSE Oxidative Stress
Kit, which uses dihydroethidium to monitor superoxide production in
the cell (MCH100111, Millipore) (Bindokas et al. 1996). ANNOVA anal-
ysis was performed for statistical significance. In parallel, Huh7 and
Mahlavu cells were also cultured into 6-well dishes for 24 h followed
by treatment with 2 μM Lanatoside C or DMSO control or selenium
deficient serum-free medium. At the end of 6 h and 12 h incubation
periods, cells were first washed three times with 1X PBS and then
dichloro-dihydro-fluorescein diacetate (DCFH-DA) solution in order
to detect ROS (particularly H2O2) in the cells (10 mM glucose, 1 mM
DCFH-DA, 10 mM HEPES dissolved in 1X PBS) (LeBel et al. 1992) was
applied onto the cells and they were incubated 15 min in dark, at
37 °C. ROS were observed in situ under the fluorescent microscope.
In vivo animal experiments
Mahlavu cells (10,000,000 cells/mouse) were injected subcuta-
neously to the flank of nude mice (8–16 weeks old) in DMEM. When
tumor volume reached ∼150 mm3, drug treatment was initiated.
Control group mice (5 mice) received only simple syrup and other
subjects received 6 mg/kg Lanatoside C (8 mice) in simple syrup by
gavage feeding (5 days/week). After 21 days of chemotherapy, nude
mice were taken to MRI (acquired with 3-T Siemens MAGNETOM Trio,
UMRAM Center, Bilkent University, Ankara Turkey). For statistical sig-
nificance, Student’s t-test analysis was performed. Animal care was
in agreement with institutional guidelines. Ethical approval was ob-
tained from Bilkent University Animal Ethics Committee (Bilkent Uni-
versity Animal Ethics Committee permit no: 2013/57).
Results
Cytotoxicities of glycosides purified from Digitalis ferruginea
Cytotoxic activities of purified glycosides obtained from the D.
ferruginea (Fig. 1) were initially investigated on both epithelial-like
(Huh7, HepG2) and mesenchymal-like (FOCUS, Mahlavu) liver can-
cer cell lines. The cardiac glycosides Lanatoside A, Lanatoside C and
Glucogitoroside showed significant levels of cytotoxicity whereas the
phenylpropanoid glycosides had no notable effects on cell growth
(Fig. 2a).
Time-dependent cytotoxic activities of cardiac glycosides were
examined with the use of RT-CES assay on PTEN adequate Huh7ells with normal Akt and ERK proteins and PTEN deficient Mahlavu
ells with hyperactive Akt and ERK proteins (Fig. 2b). This assay fur-
her confirmed that all three compounds displayed time- and dose-
ependent growth inhibitory effects (Fig. 2c). Cytotoxic effects of the
ompounds could be observed after eight hours of treatment, and
eached to its highest values upon 72 h (Fig. 2c). Data obtained from
he RT-CES assay on the cells showed a continuous increase on the
ime course of the cell growth inhibition and hence we evaluated that
hese compounds should be considered as being cytotoxic rather than
ytostatic. Therefore the molecular mechanisms underlying the cyto-
oxic activities of cardiac glycosides were further analyzed in detail
ith epithelial like Huh7 cells and PTEN deficient mesenchymal like
ahlavu cells (Fig. 2b).
haracterization of the cell death induced by cardiac glycosides
Fluorescent-activated cell sorting analysis was performed to an-
lyze cell cycle in the presence of cardiac glycosides. An increase in
he G2/M phase was observed in cells treated with Lanatoside A,
anatoside C and Glucogitoroside compared to cells in the DMSO con-
rols (Fig. 3a). To explore the death mechanism induced by Lanato-
ide A, Lanatoside C and Glucogitoroside, Huh7 and Mahlavu cells
ere treated with these compounds for 48 h. All three compounds
aused apoptotic morphological changes in both cell lines by live mi-
roscopy and nuclear staining with Hoechst compared to DMSO con-
rols (Fig. 3b). The induction of apoptotic cell death pathway was
urther confirmed at protein level by western blot analysis of PARP
ragmentation. When the Mahlavu cells treated with these com-
ounds were carefully examined, cleavage of PARP and caspase-3
as observed and in the DMSO control neither PARP nor carpase-3-
leavage could be observed (Fig. 3c). In conclusion, all these experi-
ents showed that cardiac glycosides Lanatoside A, Lanatoside C and
lucogitoroside induce caspase-related apoptosis and cell cycle ar-
est at the G2/M-phase in liver cancer cell lines. Compared to Lanato-
ide A and Glucogitoroside, Lanatoside C is the drug that is preferably
sed in clinics for cardiac patients. Thus, we selected and continued
etailed molecular analysis of cardiac glycoside induced cell death in
iver cancer cells using Lanatoside C.
xidative stress induced by Lanatoside C
Cardiac glycosides were previously shown to induce oxidative
tress by ROS production by the inhibition of Na+/K+-ATPase (Prassas
nd Diamandis 2008). Thus in this study, oxidative stress induction by
anatoside C was monitored in HCC cells. We showed that Lanatoside
treatment lead to high percentage of ROS (+) cells when compared
o DMSO controls in both Huh7 and Mahlavu cells (Fig. 4a). Selenium
eficient serum free medium grown cells were used as experimen-
al positive control for ROS generation (Irmak et al. 2003). Treatment
ith Lanatoside C resulted in about 40% ROS positivity in both Huh7
nd Mahlavu cells (Fig. 4a). In order to visualize in situ presence of
xidative stress, DCFH-DA assay was performed on these cells, which
ere treated with the Lanatoside C for either 6 h or 12 h based on
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Fig. 2. Bioactivities of the glycosides extracted from rusty foxglove. (a) Percent growth inhibitions were characterized by NCI-SRB assay on epithelial like (Huh7 and HepG2)
and mesenchymal like (Mahlavu and FOCUS) liver cancer cells which were treated for 72 h with Lanatoside A, Lanatoside C, and Glucogitoroside (4–0.25 μM) and Lugrandoside,
Ferruginoside A, and Ferruginoside B (40–2.5 μM). The experiment was performed in triplicate and the absorbance values were normalized to DMSO controls and Tz values.
(R2 > 0.8). (b) PTEN, Akt and ERK status of epithelial like Huh7 and mesenchymal like Mahlavu cells. (c) The percentage of cell growth inhibition was obtained from real-time cell
growth analysis (RT-CES assay) with Lanatoside A, Lanatoside C and Glucogitoroside for 48 h. The experiment was conducted in triplicate and was normalized to DMSO controls
and Tz (R
2 > 0.8).
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Fig. 3. Characterization of cell death. (a) FACS analysis on cancer cells treated with Lanatoside A, Lanatoside C, and Glucogitoroside or DMSO controls for 24 h representing G2/M
arrest in treated cells. All experiments were done with 2 μM of the compounds. (b) Hoechst staining of Mahlavu cells with apoptotic nuclei at 24 h. (c) PARP and caspase-3 cleavage
in Mahlavu cells treated with the glycosides for 48 h. Actin was used for equal loading.
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Fig. 4. Oxidative stress induced by Lanatoside C. Human liver cancer cells were treated with 2 μM of Lanatoside C or DMSO control for 6 h, and 12 h. Selenium deficient serum-free
medium was used as a positive control of ROS induction. (a) Cytometric analysis of oxidative stress induction. ROS positive cells are indicated with red and ROS negative cells are
shown in blue. ANNOVA was performed for statistical analysis (p-Value <0.05). (b) DCFH-DA staining of the cells under oxidative stress with fluorescent microscope (20×). (For









T-CES experiment results that indicated the start of cell death as
arly as 8 h (Fig. 2). In the presence of oxidative stress DCFH-DA dye
as oxidized to a green fluorescent molecule, DCF. Fluorescent mi-
roscopy images showed that oxidative stress triggered by Lanatoside
as early as 6-12 hours in parallel to cell death (Fig. 4b).ellular pathways targeted by Lanatoside C
Based on the finding that Lanatoside C caused ROS accumulation,
argets of ROS at the protein level was further investigated by west-
rn blot analyses. ERK, Akt and JNK proteins were previously shown to
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Fig. 5. ERK1/2 and Akt pathway activity analysis in the presence of Lanatoside C. Western blot analysis of the proteins in the PTEN adequate Huh7 and PTEN deficient Mahlavu cells
treated with 2 μM of Lanatoside C or DMSO controls for 24 h. (a) Basal Akt protein levels were the same in both cells. Mahlavu cells had active pAkt protein due to PTEN deletion
in controls and reduced pAkt levels upon Lanatoside C treatment. GSK3β protein phosphorylation was increased in Huh7 cells but was reduced in Mahlavu cells in the presence of
Lanatoside C when compared to DMSO. JNK1 protein phosphorylation was increased in both epithelial like Huh7 and mesenchymal like Mahlavu cells whereas significant increase
in pJNK2 was observed only in Mahlavu cells with Lanatoside C treatment. Due to the increase in pJNK1, downstream extrinsic apoptotic cascade activation was observed by cleaved
Caspase-8, Caspase-3, and PARP proteins in the presence of Lanatoside C. (b) Western blot results indicated an increase in pERK1/2 in Huh7 cells treated with Lanatoside C, whereas
the change in the pERK1/2 levels was masked in Mahlavu cells due to PTEN deficiency. Na+/K+-ATPase levels were the same in both cells under all conditions. (c) Involvement of












be involved in the oxidative stress induced cellular pathways (Cagnol
and Chambard 2010). Therefore these pathways were initially inves-
tigated in the presence of Lanatoside C (Fig. 5 and Suppl. Figs. 1–4).
Lanatoside C increased the phosphorylation of JNK1 induced caspase-
8 dependent apoptotic cascade in both Huh7 and PTEN deficient
Mahlavu cells (Fig. 5a and Suppl. Fig. 1). Because JNK induced apop-
tosis was dependent on GSK3β in pancreas cancer cells, we then ana-
lyzed the upstream elements of this pathway, which includes GSK3β ,
Akt and ERK. In PTEN adequate epithelial like Huh7 cells, ROS accu-
mulation due to Lanatoside C treatment lead to an increase in both
ERK and GSK3β phosphorylation. However, in PTEN deficient mes-nchymal like Mahlavu cells, ROS initiated the dephosphorylation
f Akt, leading to a decrease in GSK3β phosphorylation and an in-
rease in both JNK2 and JNK1 phosphorylation (Fig. 5a and b). On the
ther hand, there was no significant JNK2 phosphorylation in Huh7
ells, which displayed normal PI3K/Akt activities. Furthermore, we
erified the presence of previously described target of cardiac gly-
osides, Na+/K+-ATPase and both Huh7 and Mahlavu cells expressed
his protein (Fig. 5b). The mechanism of action of Lanatoside C in
TEN adequate Huh7 and PTEN deficient/Akt hyperactive Mahlavu
ells are discussed in detail with respect to genetic backgrounds of
hese cells below (Fig. 5c).
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Fig. 6. In vivo anti-tumor activity of Lanatoside C. Nude mice were treated with vehicle control or 6 mg/kg Lanatoside C. (a) The average tumor size of 5 vehicle controls and 8
Lanatoside C treated mice (∗p < 0.005). (b) The average tumor weight (∗p < 0.005). (c) The MR images were acquired at the end of 3 weeks. Upper panel represents mice taking

























n vivo anti-tumor effects of Lanatoside C on Mahlavu mice xenograft
odels
Finally, the anti-tumor activity of Lanatoside C was investigated
n nude mice tumor xenografts. Lanatoside C exhibited chemother-
peutic behaviors. Mice taking Lanatoside C (8 mice) had signif-
cant reduction in tumor volume at the end of 21 days whereas
he average tumor volume of control group (5 mice) had reached
600 mm3 (Fig. 6a). Tumor weight was also reduced by almost
0% in mice taking Lanatoside C compared to vehicle controls
Fig. 6b). Furthermore, the heterogeneity of the images from MRI
nalysis indicated the xenograft tumor tissue bared extensive necro-
is in Lanatoside C treated mice compared to vehicle controls
Fig. 6c).iscussion
Cardiac glycosides are among one of the oldest medicines and
ave been in use for centuries to treat heart failure (Prassas and
iamandis 2008). They are steroid-like compounds, which inhibit
a+/K+-ATPase and indirectly regulate cell signaling. This study in-
estigated the molecular mechanisms of the cytotoxic effects of car-
iac glycosides obtained from D. ferruginea on liver cancer cells in
hich the treatment required novel chemotherapeutic agents. Due
o various etiological factors, liver cancer has a heterogeneous genetic
ackground, which leads to the alterations of cellular signals. For this
urpose, initially, growth inhibitory effects of glycosides were inves-
igated on epithelial like (Huh7 and HepG2) and mesenchymal like
Mahlavu and FOCUS) liver cancer cells (Figs. 2 and 3). Three of the












































six extracts displayed high cytotoxicity to liver cancer cells at nano-
molar concentrations, which were reported not to be cardio-toxic
(Newman et al. 2008). While the proteins under the influence of car-
diac glycosides were reported in various cancers with the exception
of liver cancer, the comprehensive signaling analysis was not studied
in the context of epithelial vs. mesenchymal background (Newman
et al. 2008). In this study, drug resistant PTEN deficient mesenchy-
mal like Mahlavu liver cancer cells and drug sensitive PTEN adequate
Huh7 cells were selected to be studied in depth including the molec-
ular pathways involved in cell death in the presence of cardiac glyco-
side Lanatoside C (Buontempo et al. 2011; Wei et al. 2013; Yuzugullu
et al. 2009).
Cardiac glycosides have been reported to activate apoptosis or
autophagy-induced cell death in a tissue-specific manner (Wang et al.
2014; Xie and Cai 2003). In this study, we characterized liver cancer
cell death as apoptosis. Moreover, these compounds induced G2/M
cell cycle arrest in both Huh7 and Mahlavu liver cancer cells (Fig. 3).
It is known that when glycosides translocate into cytoplasm, Na+/K+-
TPase pumps become inactive. In parallel, ROS accumulation takes
place. Upon ROS accumulation, ERK1/2 and JNK proteins are activated
(Prassas and Diamandis 2008). Lanatoside C was selected to further
investigate the molecular mechanisms, because this compound has
been preferably used in clinics. Lanatoside C also promoted the ac-
cumulation of ROS in liver cancer cells, as reported with other glyco-
sides such as Bufalin and Ouabain in other cancer cells (Fig. 4). We
then identified the pathways targeted by Lanatoside C in the context
of epithelial vs. mesenchymal background. Our data with Lanatoside
C on epithelial like Huh7 are also in correlation with the previous
findings. Activation of ERK1/2 phosphorylates GSK3β , which lead to
its inactivation, hence the activation of JNK protein occurs (Marchand
et al. 2012). Huh7 cells under Lanatoside C treatment also displayed
active ERK1/2 and inactive GSK3β and as a result activation of JNK1
observed, in parallel caspase-8 cascade induction occurred (Fig. 4).
Cell death by apoptosis can be classified as being intrinsic or extrin-
sic. Their downstream differential caspase activation is an indicator
of the apoptotic pathway induction type (Fulda and Debatin 2006).
Caspase-8 cleavage is associated with the extrinsic pathway. Here,
we showed the cleavage of caspase-8 and its downstream targets
caspase-3 and PARP proteins under Lanatoside C treatment (Fig. 5a
and c).
GSK3β , which acts as a molecular effector in this pathway, was
previously shown to both trigger and inhibit apoptotic pathways
(Doble and Woodgett 2003). Un-phosphorylated form of GSK3β is
involved in the activation of caspase-9 dependent intrinsic pathway
and death-receptor initiated extrinsic apoptosis pathway is inhibited
by this protein (Fulda and Debatin 2006). Thus our data illustrated
that phosphorylation of GSK3β and hence inactivation of this pro-
tein together with the presence of cleaved caspase-8 and -3 was due
to Lanatoside C’s induction of extrinsic apoptotic pathway in epithe-
lial like liver cancer cell Huh7 through JNK1 activation (Fig. 5). How-
ever, PTEN deficient mesenchymal like Mahlavu cells did not exhibit
a significant change in the phosphorylation of ERK1/2 when com-
pared to DMSO controls. Furthermore, these cells have already ac-
tivated ERK1/2 and pGSK3β levels. In this and in our previous stud-
ies, we showed that PI3K/Akt pathway was constitutively hyperac-
tive in Mahlavu cell line due to PTEN deficiency (Fig. 2) (Buontempo
et al. 2011). Therefore the ROS-induced ERK1/2 phosphorylation was
masked by the hyperactivity of the Akt pathway (Fig. 5). Reduction in
inactive pGSK3β due to the decrease in pAkt in Mahlavu cells treated
with Lanatoside C is an opposing factor for cell survival (Fig. 5). Active
GSK3β and JNK2 were previously shown to be involved in preven-
tion of cell survival (Hu et al. 2009). Similarly increase in the levels
of phospho-JNK2 and decrease in the levels of phospho-GSK3β were
observed in Mahlavu cells treated with Lanatoside C, in favor of the
prevention of cell survival (Fig. 5). Our comparative data with drug
resistant PTEN deficient mesenchymal like Mahlavu and drug sen-itive PTEN adequate epithelial like Huh7 liver cancer cells demon-
trated that cardiac glycoside Lanatoside C can also induce cell death
y two parallel pathways. One is the induction of ERK1/2 dependent
poptosis and the other is inhibition of Akt dependent cell survival
y differential activation of JNK1 and JNK2 respectively. Furthermore
he results of the in vitro study are also correlated with in vivo data
ignifying the potential of Lanatoside C as liver cancer therapeutics
ndependent of the PTEN tumor suppressor protein status. The lack
f PTEN protein is highly correlated with the aggressive behavior
f this cancer due to Akt pathway activation and cell survival. The
resent study proposes that clinically preferred glycoside Lanatoside
can be repurposed as a chemotherapeutic supplementary agent
owards the liver cancer with both normal- and hyper-active Akt
athway.
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